What Is Kymera Therapeutics, Inc. (KYMR) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Kymera Therapeutics, Inc.'s intrinsic value is estimated at $24.80, suggesting the stock is overvalued at its current price of $112.08. With 12 out of 12 models flagging downside (-77.9% average return), the market may be pricing in unsustainable growth. Model dispersion is worth noting: PWERM targets $89.42 (-20.2%), versus Sentiment SOTP at $1.80 (-98.4%). This +78.2% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About KYMR?
12 of 13 models are currently active for KYMR. All 12 active models suggest the stock trades above fair value. The Bayesian DCF estimates KYMR's intrinsic value at $20.23, implying -82.0% downside from the current price. See which stocks rank higher →
How Does KYMR Rank in Biological Products, (No Diagnostic Substances)?
Among 145 Biological Products, (No Diagnostic Substances) stocks, KYMR ranks #12 by Quality of Company score. CirclFi's QOC score of 7.4/10 evaluates 32 fundamental signals. A score of 7.4 indicates above-average quality.
See all Most Undervalued Biological Products, (No Diagnostic Substances) Stocks →
Kymera Therapeutics, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is KYMR a Value Trap?
CirclFi's Value Trap algorithm assigns KYMR a score of 27/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for Kymera Therapeutics, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Kymera Therapeutics, Inc.'s fundamental quality profile registers 7.4/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +78.2% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every KYMR valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across KYMR's 12 active models, average confidence is 33%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad